HERPESVIRUS INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

被引:69
|
作者
STEWART, JA
REEF, SE
PELLETT, PE
COREY, L
WHITLEY, RJ
机构
[1] CTR DIS CONTROL & PREVENT,NATL IMMUNIZAT PROGRAM,ATLANTA,GA 30333
[2] UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195
[4] UNIV WASHINGTON,SCH MED,DEPT MICROBIOL,SEATTLE,WA 98195
[5] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[6] UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294
[7] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
关键词
D O I
10.1093/clinids/21.Supplement_1.S114
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Herpesviruses are among the most common causes of infections of humans. Viruses in this family share the unique biological property of being able to establish latency and to recur, Furthermore, chronic excretion of virus is not uncommon, In the immunocompromised host, including persons with human immunodeficiency virus (HIV) infection, herpesvirus disease can be particularly severe, resulting in chronic, persistent, active infection and, in some cases, life-threatening disease. The most pathogenic of the herpesviruses in patients with AIDS include herpes simplex viruses, human cytomegalovirus, and varicella-zoster virus, Disease caused by Epstein-Barr virus, particularly opportunistic malignancies, has been recognized, A new herpesvirus that is associated with Kaposi's sarcoma was recently described. On the other hand, disease caused by human herpesviruses 6 and 7 in persons infected with HIV remains to be unequivocally recognized. Prevention of exposure to herpesviruses, disease, and recurrence requires different measures than those for some of the other opportunistic infections in HIV-infected patients; this is because herpesvirus disease develops in most of these individuals as a result of reactivation rather than primary infection. Thus, approaches to the prevention and control of herpesvirus infections must be individualized according to both the type of virus as well as the type of infection (i.e., primary or recurrent). We discuss recommended measures for the prevention and control of these infections.
引用
收藏
页码:S114 / S120
页数:7
相关论文
共 50 条
  • [1] BACTERIAL ENTERIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    ANGULO, FJ
    SWERDLOW, DL
    CLINICAL INFECTIOUS DISEASES, 1995, 21 : S84 - S93
  • [2] INFECTIONS ASSOCIATED WITH BARTONELLA SPECIES IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    REGNERY, RL
    CHILDS, JE
    KOEHLER, JE
    CLINICAL INFECTIOUS DISEASES, 1995, 21 : S94 - S98
  • [3] EARLY INTERVENTION FOR PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    BRANSON, BM
    CLINICAL INFECTIOUS DISEASES, 1995, 20 : S3 - S22
  • [4] DISSEMINATED HISTOPLASMOSIS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    HAJJEH, RA
    CLINICAL INFECTIOUS DISEASES, 1995, 21 : S108 - S110
  • [5] BACTERIAL PNEUMONIA IN PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    HIRSCHTICK, RE
    GLASSROTH, J
    JORDAN, MC
    WILCOSKY, TC
    WALLACE, JM
    KVALE, PA
    MARKOWITZ, N
    ROSEN, MJ
    MANGURA, BT
    HOPEWELL, PC
    STANSELL, J
    TURNER, J
    OSMOND, D
    MERRIFIELD, C
    MOSSAR, M
    HIRSCHTICK, R
    MEISELMAN, L
    MANGHISI, KJ
    SCHNEIDER, RF
    REICHMAN, LB
    MANGURA, B
    BARNES, S
    RICHER, B
    AU, J
    COULSON, A
    CLEMENTE, V
    SARAVOLATZ, LD
    JOHNSON, C
    HUITSING, J
    KRYSTOFORSKI, A
    POOLE, WK
    RAO, AV
    CLAYTON, K
    HANSON, N
    JORDAN, M
    THOMPSON, J
    MYERS, D
    LAVANGE, L
    KATZIN, J
    FULKERSON, W
    WILCOSKY, T
    LOU, Y
    KALICA, AR
    WITTES, J
    FOLLMANN, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13): : 845 - 851
  • [6] ANIMAL-ASSOCIATED OPPORTUNISTIC INFECTIONS AMONG PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    GLASER, CA
    ANGULO, FJ
    ROONEY, JA
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) : 14 - 24
  • [8] OCCURRENCE OF INFECTIONS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    PRINCIPI, N
    MARCHISIO, P
    TORNAGHI, R
    MASSIRONI, E
    ONORATO, J
    PICCO, P
    LIBRETTI, C
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (03) : 190 - 193
  • [9] LYMPHOCYTE SUBSET CHANGES IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    HARDY, NM
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1992, 22 (05): : 286 - 289
  • [10] ADVERSE REACTIONS TO DAPSONE IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    PERTEL, P
    HIRSCHTICK, R
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) : 630 - 632